Xeris Biopharma Holdings, Inc.
XERS
Revenue
85.81M
▲11.43M▲15.36%
3 Months ChangeAssets
383.53M
▲13.34M▲3.60%
3 Months ChangeLiabilities
369.84M
▼-1.21M▼-0.3272%
3 Months ChangeFree Cash Flow
-96.62M
▼-15.69M▼-19.38%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-03-02
Form 8-K
ID: 0001867096-26-000012
2026-02-27
Form 8-K
ID: 0001867096-26-000010
2026-01-08
Form 8-K
ID: 0001867096-26-000004
2025-12-01
Form 8-K
ID: 0001867096-25-000161
2025-11-06
Form 10-Q
ID: 0001867096-25-000159
2025-11-06
Form 8-K
ID: 0001867096-25-000156
2025-08-07
Form 10-Q
ID: 0001867096-25-000136
2025-08-07
Form 8-K
ID: 0001867096-25-000130
2025-06-04
Form 8-K
ID: 0001867096-25-000104
2025-06-03
Form 8-K
ID: 0001867096-25-000100